Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tekkfund Capital is a Canadian capital markets advisory and investor relations consulting firm that helps emerging companies raise equity capital and navigate the process of going public in Canada. The firm describes itself as industry agnostic and focuses on managing public listing preparation, investor relations, media relations, and broader corporate development activities for small and microcap issuers. Public disclosures indicate it has provided business development, investor relations, and communications services to a range of Canadian public companies, including some life sciences clients, but Tekkfund itself is not a drug developer or healthcare operating company. The business appears to be founder-led by Gary Perkins.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tekkfund Capital.